Cortagen
Immune bioregulator peptide
Immune-system bioregulator.
Half-life
~ hours
Mol. weight
~ 400.4 g/mol
Sequence
Ala-Glu-Asp-Pro (AEDP)
Discussions
0 threads
Overview
A short bioregulator peptide studied for regulating gene expression in immune tissues, with proposed support for immune cell function and homeostasis. It applies the Khavinson bioregulator framework to the immune system — aiming, like thymic peptides (thymosin, thymulin), at immune regulation rather than simple stimulation.
Mechanism of action
Cortagen is a bioregulator peptide studied for regulating gene expression in immune tissues, with proposed support for immune cell function. Like the thymic peptides (thymosin alpha-1, thymulin) but via the ultra-short-peptide transcriptional framework, it is conceptualized as an immunomodulatory bioregulator rather than a simple stimulant — aiming at immune homeostasis rather than blunt activation.
Researched benefits
- Studied for immune system support
- Immunomodulatory concept (not pure stimulation)
- Short bioregulator format
Considerations
- Evidence concentrated in one tradition
- Human data limited
- Immune disorders require medical care
Key Academic Literature & Studies
Search more in PubMedPeer-reviewed citations and clinical trials evaluating Cortagen in scientific literature.
Query PubMed for recent peer-reviewed preclinical and clinical publications on Cortagen:
View Cortagen index on PubMed (NCBI)